Next Article in Journal
Full-Dimensional Ab Initio Potential Energy Surface and Vibrational Energy Levels of Li2H
Next Article in Special Issue
Perspectives on the Use of Liquid Extraction for Radioisotope Purification
Previous Article in Journal
Bioactive Compounds, Antioxidant Activity, and Biological Effects of European Cranberry (Vaccinium oxycoccos)
Previous Article in Special Issue
A Flexible Synthesis of 68Ga-Labeled Carbonic Anhydrase IX (CAIX)-Targeted Molecules via CBT/1,2-Aminothiol Click Reaction
Article Menu
Issue 1 (January-1) cover image

Export Article

Open AccessArticle

Innovative Target for Production of Technetium-99m by Biomedical Cyclotron

1
Legnaro National Laboratories, Italian National Institute for Nuclear Physics (LNL-INFN), Viale dell’Università 2, 35020 Legnaro PD, Italy
2
Medical Physics Department, University Hospital “S. Orsola-Malpighi”, 40100 Bologna, Italy
*
Author to whom correspondence should be addressed.
Deceased 16 March 2018
Molecules 2019, 24(1), 25; https://doi.org/10.3390/molecules24010025
Received: 30 November 2018 / Revised: 19 December 2018 / Accepted: 19 December 2018 / Published: 21 December 2018
  |  
PDF [6529 KB, uploaded 21 December 2018]
  |  

Abstract

Technetium-99m (99mTc) is the most used radionuclide worldwide in nuclear medicine for diagnostic imaging procedures. 99mTc is typically extracted from portable generators containing 99Mo, which is produced normally in nuclear reactors as a fission product of highly enriched Uranium material. Due to unexpected outages or planned and unplanned reactor shutdown, significant 99mTc shortages appeared as a problem since 2008 The alternative cyclotron-based approach through the 100Mo(p,2n)99mTc reaction is considered one of the most promising routes for direct 99mTc production in order to mitigate potential 99Mo shortages. The design and manufacturing of appropriate cyclotron targets for the production of significant amounts of a radiopharmaceutical for medical use is a technological challenge. In this work, a novel solid target preparation method was developed, including sputter deposition of a dense, adherent, and non-oxidized Mo target material onto a complex backing plate. The latter included either chemically resistant sapphire or synthetic diamond brazed in vacuum conditions to copper. The target thermo-mechanical stability tests were performed under 15.6 MeV proton energy and different beam intensities, up to the maximum provided by the available GE Healthcare (Chicago, IL, USA) PET trace medical cyclotron. The targets resisted proton beam currents up to 60 µA (corresponding to a heat power density of about 1 kW/cm2) without damage or Mo deposited layer delamination. The chemical stability of the proposed backing materials was proven by gamma-spectroscopy analysis of the solution obtained after the standard dissolution procedure of irradiated targets in H2O2. View Full-Text
Keywords: cyclotron target; radiopharmaceutical production technology; magnetron sputtering; vacuum brazing cyclotron target; radiopharmaceutical production technology; magnetron sputtering; vacuum brazing
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Skliarova, H.; Cisternino, S.; Cicoria, G.; Marengo, M.; Palmieri, V. Innovative Target for Production of Technetium-99m by Biomedical Cyclotron. Molecules 2019, 24, 25.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top